Stopping Paxlovid before finishing the full five-day course allows the virus to resume replicating in your body, potentially undoing the progress the drug has made. There are no withdrawal symptoms from stopping early, but the incomplete treatment may leave enough active virus to cause a rebound of symptoms, reduce the drug’s overall effectiveness at preventing severe illness, and possibly contribute to prolonged infection.
How the Five-Day Course Works
Paxlovid is actually two medications packaged together. Two of the three pills in each dose contain the active antiviral, which blocks an enzyme the virus needs to assemble functional copies of itself. Without that enzyme, the virus particles released from infected cells can no longer enter new cells, and the infection stalls. The third pill slows the breakdown of the antiviral in your liver so it stays in your system longer and at higher concentrations.
The five-day course is designed to maintain drug levels long enough to suppress viral replication while your immune system clears the remaining virus. If you stop on day two or three, you remove that suppressive pressure before your body has finished the job. The virus doesn’t die instantly when exposed to the drug. It needs sustained exposure over multiple days to be effectively neutralized.
The Rebound Problem
One of the most discussed consequences of incomplete treatment is COVID rebound, a return of symptoms or a new positive test three to seven days after you seemed to be recovering. Rebound can happen even in people who finish the full course, but the CDC has noted that early discontinuation of antiviral treatment is one plausible explanation for higher rebound rates among Paxlovid users.
Researchers at UC San Diego studied a rebound patient and found that the virus had not developed resistance to the drug. It was still fully sensitive to Paxlovid. Instead, the rebound appeared to result from insufficient drug exposure: not enough of the medication reached infected cells to stop all viral replication. Cutting the course short amplifies exactly this problem by reducing total drug exposure even further.
The reassuring news is that rebound symptoms are typically mild and resolve within a few days. Studies suggest there is no increased risk of severe COVID illness in people who experience rebound after antiviral treatment. But a rebound does mean additional days of feeling sick, additional days of being contagious, and the frustration of thinking you were better only to backslide.
Reduced Protection Against Severe Illness
Paxlovid’s main purpose is to keep high-risk patients out of the hospital. The drug works best when taken early in the course of illness, ideally within five days of symptom onset, because once the virus has caused significant damage to tissues and organs, an antiviral can’t reverse it. The drug prevents new damage by stopping the virus from spreading to more cells.
Stopping early shortens the window during which the drug is actively suppressing viral replication. For someone at high risk of severe COVID (due to age, immune suppression, or chronic conditions), this means giving up a portion of the protection the drug was prescribed to provide. The full five days were chosen because clinical trials showed that duration was effective at reducing hospitalizations and deaths. There is no evidence that a shorter course provides the same benefit.
No Withdrawal Symptoms, but No Reason to Stop
Unlike some medications that require gradual tapering, Paxlovid does not cause physiological withdrawal if you stop abruptly. You won’t feel worse from discontinuing the pills themselves. The risk is entirely about what the virus does once the drug is no longer suppressing it.
The most common reason people consider stopping early is the side effects. Paxlovid is well known for causing a bitter or metallic taste in the mouth, sometimes described as “Paxlovid mouth.” Diarrhea and nausea are also reported. These side effects are unpleasant but temporary, and they resolve once you finish the course. For most people, tolerating a few days of bad taste is a reasonable trade-off for the protection the drug offers.
What to Do If You Miss a Dose
If you’ve already missed a dose rather than intentionally stopping, the FDA’s guidance is straightforward. If it’s been less than eight hours since you were supposed to take it, take it as soon as you remember. If more than eight hours have passed, skip that dose entirely and take the next one at your regular time. Do not double up to make up for a missed dose. Then continue through the rest of your five-day course as planned.
If you’re thinking about stopping because of side effects or because you feel better, the improvement you’re feeling is likely because the drug is working. Feeling better on day three doesn’t mean the virus is gone. It means the medication is successfully suppressing replication, and your immune system needs the remaining days of support to finish clearing the infection. Completing all five days gives you the best chance of staying out of the hospital and avoiding a rebound.